Maekawa Yuka Muramatsu, Horie Kengo, Iinuma Koji, Takai Manabu, Ohzawa Kaori, Tsuchiya Tomohiro, Kato Daiki, Taniguchi Tomoki, Ito Hiroki, Hishida Seiji, Nakane Keita, Mizutani Kosuke, Koie Takuya, Kato Taku
Department of Urology, Gifu University Graduate School of Medicine, Gifu Japan.
Department of Urology, Japanese Red Cross Takayama Hospital, Takayama, Japan.
Transplant Proc. 2020 Jan-Feb;52(1):162-168. doi: 10.1016/j.transproceed.2019.10.025. Epub 2019 Dec 31.
This study aimed to evaluate predictive factors for graft loss in patients who received kidney transplantation (KT) from living kidney donors (LKDs) at a single institute in Japan.
Our study focused on patients with end-stage renal disease who underwent KT from LKDs and were followed up for at least 1 year after surgery. The primary end point was graft survival (GS). GS after KT was analyzed using the Kaplan-Meier method. GS according to subgroup classification was analyzed using the log-rank test. A multivariate analysis was performed using a Cox proportional hazard model.
The median follow-up period was 105.5 months after KT. The 5- and 10-year GS rates were 97.8% and 96.0% in KT recipients (KTRs) without posttransplant diabetes mellitus (PTDM) and 89.9% and 63.2% in those with PTDM, respectively. The rate of graft loss was significantly higher in KTRs with PTDM than in those without PTDM (P < .001). Of the KTRs whose diabetes mellitus (DM) was cured after KT, those who underwent dialysis because of diabetic nephropathy had no graft loss. In the multivariate analysis, the serum creatinine level at 1 month after KT, PTDM, and human leukocyte antigen mismatches were significantly associated with graft loss after KT.
In this study, the rate of graft loss in KTRs with PTDM was significantly higher than that of KTRs without PTDM. However, among KTRs whose DM was cured after KT, those who underwent dialysis because of diabetic nephropathy had no graft loss.
本研究旨在评估在日本一家机构接受活体肾移植(KT)的患者中移植肾丢失的预测因素。
我们的研究聚焦于接受来自活体供肾者KT的终末期肾病患者,并在术后至少随访1年。主要终点是移植肾存活(GS)。采用Kaplan-Meier法分析KT后的GS。根据亚组分类的GS采用对数秩检验进行分析。使用Cox比例风险模型进行多变量分析。
KT后的中位随访期为105.5个月。无移植后糖尿病(PTDM)的KT受者(KTRs)的5年和10年GS率分别为97.8%和96.0%,而有PTDM的患者分别为89.9%和63.2%。有PTDM的KTRs的移植肾丢失率显著高于无PTDM的患者(P <.001)。在KT后糖尿病(DM)治愈的KTRs中,因糖尿病肾病接受透析的患者无移植肾丢失。在多变量分析中,KT后1个月的血清肌酐水平、PTDM和人类白细胞抗原错配与KT后的移植肾丢失显著相关。
在本研究中,有PTDM的KTRs的移植肾丢失率显著高于无PTDM的KTRs。然而,在KT后DM治愈的KTRs中,因糖尿病肾病接受透析的患者无移植肾丢失。